Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients.

Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M, Gordon NB, Kleinerman ES.

Mol Cancer Ther. 2018 Jun;17(6):1315-1323. doi: 10.1158/1535-7163.MCT-17-0901. Epub 2018 Mar 28.

PMID:
29592877
2.

Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy.

Santiago-O'Farrill JM, Kleinerman ES, Hollomon MG, Livingston A, Wang WL, Tsai JW, Gordon NB.

Oncotarget. 2017 Aug 17;9(2):1602-1616. doi: 10.18632/oncotarget.20308. eCollection 2018 Jan 5.

3.

Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.

Player A, Oguamanam T, Okanmelu J, Burrell K, Hollomon M.

BMC Res Notes. 2014 Aug 7;7:501. doi: 10.1186/1756-0500-7-501.

4.

Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells.

Hollomon MG, Gordon N, Santiago-O'Farrill JM, Kleinerman ES.

BMC Cancer. 2013 Oct 26;13:500. doi: 10.1186/1471-2407-13-500.

5.

Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases.

Huang G, Yu L, Cooper LJ, Hollomon M, Huls H, Kleinerman ES.

Cancer Res. 2012 Jan 1;72(1):271-81. doi: 10.1158/0008-5472.CAN-11-2778. Epub 2011 Nov 10.

6.

Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.

Yu L, Su B, Hollomon M, Deng Y, Facchinetti V, Kleinerman ES.

Cancer Res. 2010 Feb 15;70(4):1334-43. doi: 10.1158/0008-5472.CAN-09-2795. Epub 2010 Feb 2.

Supplemental Content

Loading ...
Support Center